SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Biotechnology

Healthcare
$29.68 +2.49%

+$0.45 today

Market cap
$993.14M
Beta
-0.34
P/E (TTM)
-14.1
EPS (TTM)
-$1.32
52W Low $17.06High $32.44

Volume 0.10M

Average 0.09M

SGP Total Current Assets

All assets expected to be converted to cash or used up within one year.

SpyGlass Pharma, Inc. Common StockNASDAQ: SGP

Total Current Assets · Q1 FY2026 · quarter ended Mar 2026

Total current assets of $253.36M in Q1 FY2026

Q1 FY2026 total current assets was $253.36M.

Context

  • Total current assets amounted to 98.1% of total assets at the end of Q1 FY2026.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$253.36M+132.9% QoQ
Last fiscal yearDec 2025
$108.77M— YoY
Total Current Assets past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Total Current Assets history

USD · from the balance sheet

Latest · FY2025
108.77M USD
Year-over-year change
—

Total Current Assets vs competitors

How SGP compares with its peers on the latest reported figures

  • Peers report in different currencies, so total current assets is compared through growth and share of total assets rather than absolute size.
  • Total current assets amounts to 98.1% of total assets for SGP, versus a peer median of 86.6%.
SGP Competitors
Total Current Assets for SGP and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ALCAlcon Inc.Sep 2026$6.97B USD+10.2%+7.5%22.2%
BLCOBausch + Lomb CorporationJun 2026$2.92B USD+2.7%+11.7%21.1%
OCULOcular Therapeutix, Inc.Mar 2026$706M USD+82.1%+82.1%96.4%
GKOSGlaukos CorporationJun 2026$515.78M USD+18.3%+2.3%56.0%
STAASTAAR Surgical CompanyApr 2026$312.4M USD-4.3%-0.0%69.2%
RXSTRxSight, Inc.Mar 2026$279.23M USD-3.2%+28.8%91.9%
SGPSpyGlass Pharma, Inc. Common StockMar 2026$253.36M USD——98.1%
EYPTEyePoint Pharmaceuticals, Inc.Mar 2026$249.5M USD-23.7%+23.9%86.6%
OCSOculis Holding AGMar 2026CHF 226.36M CHF+19.9%+110.0%93.1%
SGHTSight Sciences, Inc.Mar 2026$106.51M USD-16.1%-18.7%97.1%
Peer median (excluding SGP) —+2.7%+11.7%86.6%

Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Intrinsic Alpha fair value

Locked

Current Price

$29.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.